AYUMI Pharmaceutical Holdings Co., Ltd. is a life sciences. Over the past three years, AYUMI Pharmaceutical Holdings Co., Ltd. has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Other
Licensing, acquisition, and partnership transactions involving AYUMI Pharmaceutical Holdings Co., Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| AYUMI Pharmaceutical | GNI Group Ltd. | Small Molecules | Approved | acquisition | Jul 2, 2026 |
Therapeutic areas and modalities where AYUMI Pharmaceutical Holdings Co., Ltd. is most active based on deal history and clinical trial data.
Use Solidus to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
AYUMI Pharmaceutical Holdings Co., Ltd. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, AYUMI Pharmaceutical Holdings Co., Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for AYUMI Pharmaceutical Holdings Co., Ltd. include Other (2 deals and trials). In terms of modality, AYUMI Pharmaceutical Holdings Co., Ltd. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for AYUMI Pharmaceutical Holdings Co., Ltd. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against AYUMI Pharmaceutical Holdings Co., Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.